Drug recall D-0471-2024
Product
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
Reason for recall
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Lots and codes
Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025
Recall details
- Recalling firm
- Cipla USA, Inc., Warren, NJ
- Quantity
- 59244/3ml FFS packs
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 26, 2024
- Terminated
- July 9, 2025
Related products
- Ipratropium Bromide and Albuterol Sulfate – drug information
- NDC 69097-173 Ipratropium Bromide and Albuterol Sulfate · Albuterol Sulfate 2.5 mg/3mL; Ipratropium Bromide .5 mg/3mL · Cipla USA Inc.